Las cookies nos ayudan a ofrecerle un mejor servicio. En el uso de nuestros servicios, usted está de acuerdo con el uso de cookies. Leer Más

Junio 27, 2017   |   Noticias

BIAL at the 21st International Congress of Parkinson’s Disease and Movement Disorders

The event took place in Vancouver, Canada

BIAL attended this Congress with a booth and the presentation of 4 posters on Opicapone, the second medicine of BIAL's own Research & Development for Parkinson’s Disease, which was approved by the European Commission in 2016.

This is one of the most relevant events within the area, and it is organized by the International Parkinson and Movement Disorder Society.

More than 4.000 people from 89 counties and 40 companies attended this 21st edition.

Comparta